Shell
US.SHEL
92.95
+0.62
+0.67%
Shell
92.95
+0.62
+0.67%
Collector offline (last heartbeat: 15983s ago)
· 2026-09-04 20:02
Pre-market
92.94
+0.66%
After-hours
92.90
-0.05%
Overnight
93.41
+1.17%
Revenue annual, last 8 years
Latest year -6.13% YoY
Margins
- Gross margin
- 15.92%
- Operating margin
- 10.33%
- Net margin
- 6.68%
Key ratios & quality
- Enterprise value
- 287.60B
- Altman Z-Score
- 2.45
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ AI Financial Health how this is computed
Fair
- Altman Z-Score is 2.45, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 388.38B | 344.88B | 180.54B | 261.50B | 381.31B | 316.62B | 284.31B | 266.89B |
| Gross profit | 44.88B | 36.76B | -13.00B | 35.85B | 78.78B | 47.21B | 45.94B | 42.50B |
| Selling & admin expenses | 11.36B | 10.49B | 9.88B | 11.33B | 12.88B | 13.43B | 12.44B | 12.61B |
| Research & development | 986.00M | 962.00M | 907.00M | 815.00M | 1.08B | 1.29B | 1.10B | 1.17B |
| Operating profit | 31.19B | 22.95B | -25.53B | 22.28B | 63.11B | 30.74B | 29.99B | 27.58B |
| Pretax profit | 35.62B | 25.49B | -26.97B | 29.83B | 64.82B | 32.63B | 29.92B | 29.76B |
| Tax | 11.72B | 9.05B | -5.43B | 9.20B | 21.94B | 12.99B | 13.40B | 11.64B |
| Net profit | 23.91B | 16.43B | -21.53B | 20.63B | 42.87B | 19.64B | 16.52B | 18.12B |
| Basic EPS | 6 | 4 | -6 | 5 | 12 | 6 | 5 | 6 |
| Diluted EPS | 5.60 | 3.90 | -5.56 | 5.14 | 11.42 | 5.70 | 5.06 | 6.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 69.23B | 65.41B | 68.15B | 64.09B | 69.69B | 94.66B |
| Gross profit | 12.71B | 9.73B | 11.58B | 7.28B | 13.43B | 18.48B |
| Selling & admin expenses | 2.84B | 3.08B | 3.26B | 3.43B | 2.80B | 2.91B |
| Research & development | 185.00M | 278.00M | 409.00M | 298.00M | 167.00M | 277.00M |
| Operating profit | 9.47B | 6.01B | 7.73B | 3.16B | 10.37B | 15.18B |
| Pretax profit | 8.96B | 5.98B | 7.92B | 6.90B | 9.33B | 15.75B |
| Tax | 4.08B | 2.33B | 2.50B | 2.72B | 3.57B | 4.95B |
| Net profit | 4.88B | 3.64B | 5.42B | 4.18B | 5.76B | 10.81B |
| Basic EPS | 2 | 1 | 2 | 1 | 2 | 4 |
| Diluted EPS | 1.58 | 1.20 | 1.80 | 1.42 | 2.00 | 3.84 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 97.48B | 92.69B | 91.95B | 128.77B | 165.94B | 134.12B | 127.93B | 107.17B |
| Cash & ST investments | 26.30B | 17.62B | 31.77B | 36.86B | 40.09B | 38.31B | 37.84B | 29.63B |
| Inventory | 21.12B | 24.07B | 19.46B | 25.26B | 31.89B | 26.02B | 23.43B | 22.22B |
| Total assets | 399.19B | 404.34B | 379.27B | 404.38B | 443.02B | 406.27B | 387.61B | 370.35B |
| Total current liabilities | 77.81B | 79.62B | 73.71B | 95.55B | 121.31B | 95.47B | 95.03B | 82.42B |
| Short-term debt | 10.13B | 15.06B | 16.90B | 8.22B | 9.00B | 9.93B | 11.63B | 9.13B |
| Long-term debt | 53.69B | 55.78B | 66.84B | 57.50B | 51.53B | 48.54B | 41.46B | 42.19B |
| Total liabilities | 196,660,000,000.00 | 213,873,000,000.00 | 220,731,000,000.00 | 229,054,000,000.00 | 250,427,000,000.00 | 217,908,000,000.00 | 207,441,000,000.00 | 195,031,000,000.00 |
| Total equity | 202.53B | 190.46B | 158.54B | 175.33B | 192.60B | 188.36B | 180.17B | 175.32B |
| Retained earnings | 182.61B | 172.43B | 142.62B | 153.03B | 169.48B | 165.92B | 158.83B | 153.53B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 126.65B | 121.60B | 121.18B | 107.17B | 119.16B | 122.83B |
| Cash & ST investments | 35.60B | 32.68B | 33.05B | 29.63B | 23.12B | 31.37B |
| Inventory | 22.98B | 23.28B | 22.91B | 22.22B | 28.70B | 26.64B |
| Total assets | 389.25B | 387.92B | 377.74B | 370.35B | 380.60B | 380.51B |
| Total current liabilities | 96.08B | 92.02B | 89.62B | 82.42B | 93.47B | 85.61B |
| Short-term debt | 11.39B | 10.46B | 10.02B | 9.13B | 10.06B | 8.54B |
| Long-term debt | -- | -- | -- | 42.19B | 40.36B | -- |
| Total liabilities | 208,576,000,000.00 | 204,833,000,000.00 | 199,915,000,000.00 | 195,031,000,000.00 | 205,997,000,000.00 | 198,730,000,000.00 |
| Total equity | 180.67B | 183.09B | 177.82B | 175.32B | 174.60B | 181.78B |
| Retained earnings | 157.53B | 155.46B | 155.16B | 153.53B | 153.45B | 160.70B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 53.09B | 42.18B | 34.11B | 45.10B | 68.41B | 54.19B | 54.69B | 42.86B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 30.07B | 19.21B | 17.52B | 26.10B | 45.81B | 31.20B | 35.09B | 23.92B |
| Dividends paid | -15.68B | -15.20B | -7.42B | -6.25B | -7.41B | -8.39B | -8.67B | -8.47B |
| Stock buybacks / issuance | -5.06B | -11.36B | -2.08B | -3.17B | -19.03B | -15.51B | -14.69B | -15.18B |
| Ending cash balance | 26.74B | 18.06B | 31.83B | 36.97B | 40.25B | 38.77B | 39.11B | 30.22B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.28B | 11.94B | 12.21B | 9.44B | 6.06B | 21.43B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 5.53B | 6.49B | 7.65B | 4.19B | 2.31B | 17.40B |
| Dividends paid | -2.18B | -2.12B | -2.10B | -2.07B | -2.10B | -2.16B |
| Stock buybacks / issuance | -4.08B | -3.54B | -3.77B | -3.80B | -3.61B | -3.00B |
| Ending cash balance | 35.60B | 32.68B | 33.05B | 30.22B | 23.12B | 31.37B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE % | -- | -- | -13.96 | 12.28 | 23.35 | 10.27 | 8.82 | 10.11 |
| ROA % | -- | -- | -5.72 | 5.13 | 9.99 | 4.56 | 4.05 | 4.71 |
| ROIC % | -- | -- | -7.29 | 8.39 | 16.51 | 7.59 | 6.84 | 7.70 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- | 8.15 | 12.97 |
| EBIT margin % | 10.09 | 8.71 | -12.69 | 12.79 | 18.02 | 11.77 | 12.23 | 12.93 |
| FCF / sales % | 7.74 | 5.57 | 9.70 | 9.98 | 12.01 | 9.85 | 12.34 | 8.96 |
| Current ratio | 1.25 | 1.16 | 1.25 | 1.35 | 1.37 | 1.40 | 1.35 | 1.30 |
| Quick ratio | 0.81 | 0.71 | 0.83 | 0.84 | 0.75 | 0.89 | 0.81 | 0.82 |
| Debt / assets | 38.67 | 51.71 | 69.55 | 51.80 | 43.99 | 43.70 | 43.23 | 43.38 |
| LT debt / equity | 33.57 | 43.63 | 58.67 | 47.03 | 39.27 | 38.37 | 36.71 | 38.14 |
| Interest coverage | 10.96 | 6.59 | -5.65 | 9.27 | 17.61 | 8.05 | 7.16 | 7.28 |
| Revenue CAGR (3Y) % | 13.59 | 13.87 | -16.05 | -12.35 | 3.40 | 20.59 | 2.83 | -11.21 |
| Net income CAGR (3Y) % | 129.22 | 51.29 | -- | -4.87 | 38.74 | -- | -7.14 | -25.02 |
| FCF CAGR (3Y) % | 101.44 | -- | 5.77 | -4.61 | 33.61 | 21.21 | 10.36 | -19.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 7.40 | 7.42 | 8.05 | 10.11 | 10.64 | 14.35 |
| ROA % | 3.42 | 3.48 | 3.79 | 4.71 | 4.87 | 6.76 |
| ROIC % | 5.93 | 5.99 | 6.52 | 7.70 | 8.22 | 11.03 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 11.62 | 11.42 | 11.83 | 12.93 | 13.17 | 15.18 |
| FCF / sales % | 11.13 | 10.57 | 9.81 | 8.96 | 7.74 | 10.64 |
| Current ratio | 1.32 | 1.32 | 1.35 | 1.30 | 1.27 | 1.43 |
| Quick ratio | 0.87 | 0.85 | 0.87 | 0.82 | 0.82 | 0.98 |
| Debt / assets | 42.79 | 41.78 | 42.07 | 43.38 | 43.58 | 40.42 |
| LT debt / equity | 36.42 | 36.01 | 36.37 | 38.14 | 37.78 | 35.70 |
| Interest coverage | 6.78 | 6.68 | 6.68 | 7.28 | 6.91 | 8.77 |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Chemicals and Products50.22%
Marketing43.99%
Upstream14.18%
Integrated Gas14.10%
Renewables and Energy Solutions11.07%
Quote time 2026-09-04 20:02:30 · For reference only, not investment advice.